1. Resveratrol: biology, metabolism, and detrimental role on the tumor microenvironment of colorectal cancer.
- Author
-
Dariya, Begum, Girish, Bala Prabhakar, Merchant, Neha, Srilatha, Mundla, and Nagaraju, Ganji Purnachandra
- Subjects
- *
NF-kappa B , *VASCULAR endothelial growth factors , *MITOGEN-activated protein kinases , *METHYLATION , *KILLER cells , *CELL physiology , *ANTINEOPLASTIC agents , *PHARMACEUTICAL chemistry , *NEUTROPHILS , *MICRORNA , *COLORECTAL cancer , *CELLULAR signal transduction , *TRANSCRIPTION factors , *MULTIDRUG resistance , *RESVERATROL , *FIBROBLASTS , *METASTASIS , *HYDROXYLATION , *MOLECULAR structure , *DRUG efficacy , *LIPOPOLYSACCHARIDES , *BIOAVAILABILITY , *DISEASE progression , *TRANSFORMING growth factors-beta , *INTERLEUKINS , *TUMOR necrosis factors , *WNT proteins , *PHARMACODYNAMICS - Abstract
A substantial increase in colorectal cancer (CRC)–associated fatalities can be attributed to tumor recurrence and multidrug resistance. Traditional treatment options, including radio- and chemotherapy, also exhibit adverse side effects. Ancient treatment strategies that include phytochemicals like resveratrol are now widely encouraged as an alternative therapeutic option. Resveratrol is the natural polyphenolic stilbene in vegetables and fruits like grapes and apples. It inhibits CRC progression via targeting dysregulated cancer-promoting pathways, including PI3K/Akt/Kras, targeting transcription factors like NF-κB and STAT3, and an immunosuppressive tumor microenvironment. In addition, combination therapies for cancer include resveratrol as an adjuvant to decrease multidrug resistance that develops in CRC cells. The current review discusses the biology of resveratrol and explores different mechanisms of action of resveratrol in inhibiting CRC progression. Further, the detrimental role of resveratrol on the immunosuppressive tumor microenvironment of CRC has been discussed. This review illustrates clinical trials on resveratrol in different cancers, including resveratrol analogs, and their efficiency in promoting CRC inhibition. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF